Figure 2.

Proportions of γδ T cells, Vγ9Vδ2 T cells and NKG2D⁺ γδ T cells in patients with HCC following amplification. (A) The proportions of γδ T cells out of the total number of T cells in peripheral blood samples of patients with HCC and healthy donors prior to and following amplification, and (B) quantification. (C) The proportions of Vγ9Vδ2 T cells out of the total number of γδ T cells prior to and following amplification and (D) quantification. (E) The proportions of NKG2D⁺ γδ T cells prior to and following amplification and (F) quantification. Results are expressed as the mean ± standard deviation. *P<0.05 with comparisons indicated by lines. NKG2D, natural killer receptor group 2, member D; P, patients; H, healthy controls.